| Data |
Ora |
Fonte |
Titolo |
|---|
| 13/1/2025 | 13:30 | EDGAR2 | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |
| 08/1/2025 | 13:00 | EDGAR2 | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |
| 08/1/2025 | 13:00 | PRNUS | I-Mab Announces Open Market Purchases of Company American.. |
| 06/1/2025 | 13:00 | EDGAR2 | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |
| 06/1/2025 | 13:00 | PRNUS | I-Mab Announces Portfolio Prioritization of Givastomig.. |
| 21/11/2024 | 13:00 | PRNUS | I-Mab to Participate at the Piper Sandler Healthcare.. |
| 14/11/2024 | 13:00 | EDGAR2 | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |
| 14/11/2024 | 13:00 | PRNUS | I-Mab Reports Third Quarter 2024 Results |
| 06/11/2024 | 13:00 | EDGAR2 | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |
| 06/11/2024 | 13:00 | PRNUS | I-Mab Appoints Sean Fu, PhD, MBA, as Chief Executive Officer |
| 05/11/2024 | 22:00 | EDGAR2 | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |
| 31/10/2024 | 12:00 | PRNUS | I-Mab to Release Q3 2024 Financial Results on November 14,.. |
| 30/10/2024 | 12:00 | PRNUS | I-Mab to Present Givastomig Phase 1 Optimal Dose Estimation.. |
| 28/10/2024 | 12:00 | PRNUS | I-Mab to Participate at the Truist Securities BioPharma.. |
| 24/10/2024 | 13:00 | EDGAR2 | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |
| 23/9/2024 | 13:00 | EDGAR2 | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |
| 16/9/2024 | 22:01 | EDGAR2 | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |
| 16/9/2024 | 22:01 | PRNUS | I-Mab Presents Updated Phase 1 Givastomig Data at ESMO 2024 |
| 10/9/2024 | 13:00 | PRNUS | I-Mab Presents Positive Uliledlimab Pharmacokinetics Data at.. |
| 30/8/2024 | 21:23 | EDGAR2 | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |
| 28/8/2024 | 13:00 | EDGAR2 | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |
| 28/8/2024 | 13:00 | PRNUS | I-Mab Reports 1H 2024 Financial Results, Pipeline Progress,.. |
| 26/8/2024 | 13:00 | PRNUS | I-Mab to Participate at the H.C. Wainwright 26th Annual.. |
| 14/8/2024 | 13:00 | PRNUS | I-Mab to Release 1H 2024 Financial Results on August 28,.. |
| 07/8/2024 | 13:59 | EDGAR2 | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |
| 07/8/2024 | 13:00 | PRNUS | I-Mab Appoints U.S. Auditor, PricewaterhouseCoopers LLP.. |
| 26/7/2024 | 12:20 | EDGAR2 | Form 144 - Report of proposed sale of securities |
| 17/7/2024 | 12:24 | EDGAR2 | Form 144 - Report of proposed sale of securities |
| 15/7/2024 | 13:45 | EDGAR2 | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |
| 15/7/2024 | 13:30 | PRNUS | I-Mab Announces Leadership Transitions |
| 06/6/2024 | 13:14 | EDGAR2 | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |
| 06/6/2024 | 13:00 | PRNUS | I-Mab Appoints Phillip Dennis, MD, PhD, as Chief Medical.. |
| 05/6/2024 | 13:11 | EDGAR2 | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |
| 05/6/2024 | 13:00 | PRNUS | I-Mab Announces Collaboration with Bristol Myers Squibb to.. |
| 30/5/2024 | 23:33 | EDGAR2 | Form S-8 - Securities to be offered to employees in employee.. |
| 23/5/2024 | 23:11 | EDGAR2 | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |
| 23/5/2024 | 23:05 | GLOBE | I-Mab Announces Encouraging Phase 1 Clinical Data of.. |
| 22/5/2024 | 13:00 | PRNUS | I-Mab to Participate at the Jefferies Global Healthcare.. |
| 30/4/2024 | 13:00 | PRNUS | I-MAB Filed 2023 Annual Report on Form 20-F |
| 05/4/2024 | 13:00 | PRNUS | I-Mab to Participate at the 23rd Annual Needham Virtual.. |
| 02/4/2024 | 22:01 | PRNUS | I-Mab Announces Closing of the Divestiture of Business.. |
| 14/3/2024 | 22:00 | PRNUS | I-Mab Reports Full Year 2023 Financial Results and Business.. |
| 09/2/2024 | 22:01 | EDGAR2 | Form SC 13G/A - Statement of acquisition of beneficial.. |
| 08/2/2024 | 12:07 | EDGAR2 | Form 144 - Report of proposed sale of securities |
| 07/2/2024 | 12:52 | EDGAR2 | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |
| 07/2/2024 | 12:00 | PRNUS | I-Mab Signs Agreement to Divest its Assets and Business.. |
| 07/2/2024 | 02:55 | EDGAR2 | Form SCHEDULE 13G - Statement of acquisition of beneficial.. |
| 06/2/2024 | 12:34 | EDGAR2 | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |
Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
